Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1978 2
1979 2
1980 2
1981 4
1983 8
1984 2
1985 3
1986 13
1987 9
1988 10
1989 11
1990 9
1991 12
1992 9
1993 9
1994 3
1995 11
1996 23
1997 13
1998 11
1999 7
2000 9
2001 8
2002 9
2003 5
2004 8
2005 12
2006 15
2007 19
2008 10
2009 4
2010 10
2011 13
2012 9
2013 6
2014 8
2015 9
2016 10
2017 12
2018 12
2019 2
2020 8
2021 3
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

355 results
Results by year
Filters applied: . Clear all
Page 1
ETAP changes.
Vermeulen NP, Seegal RF, Koeman JH. Vermeulen NP, et al. Environ Toxicol Pharmacol. 2001 Jun;10(1-2):V. doi: 10.1016/s1382-6689(01)00086-2. Environ Toxicol Pharmacol. 2001. PMID: 11382557 No abstract available.
Enzyme-catalyzed activation of anticancer prodrugs.
Rooseboom M, Commandeur JN, Vermeulen NP. Rooseboom M, et al. Among authors: vermeulen np. Pharmacol Rev. 2004 Mar;56(1):53-102. doi: 10.1124/pr.56.1.3. Pharmacol Rev. 2004. PMID: 15001663 Review.
Cytochromes P450 and drug resistance.
Doehmer J, Goeptar AR, Vermeulen NP. Doehmer J, et al. Among authors: vermeulen np. Cytotechnology. 1993;12(1-3):357-66. doi: 10.1007/BF00744673. Cytotechnology. 1993. PMID: 7764457 Review.
The EU chemicals strategy for sustainability: in support of the BfR position.
Barile FA, Berry SC, Blaauboer B, Boobis A, Bolt HM, Borgert C, Dekant W, Dietrich D, Domingo JL, Galli CL, Gori GB, Greim H, Hengstler JG, Heslop-Harrison P, Kacew S, Marquardt H, Mally A, Pelkonen O, Savolainen K, Testai E, Tsatsakis A, Vermeulen NP. Barile FA, et al. Among authors: vermeulen np. Arch Toxicol. 2021 Sep;95(9):3133-3136. doi: 10.1007/s00204-021-03125-w. Epub 2021 Aug 7. Arch Toxicol. 2021. PMID: 34363510 Free PMC article.
Editorial.
Koeman JH, Vermeulen NP. Koeman JH, et al. Among authors: vermeulen np. Environ Toxicol Pharmacol. 1996 Feb 15;1(1):v. doi: 10.1016/s1382-6689(96)90001-0. Environ Toxicol Pharmacol. 1996. PMID: 21781656 No abstract available.
The role of water molecules in computational drug design.
de Beer SB, Vermeulen NP, Oostenbrink C. de Beer SB, et al. Among authors: vermeulen np. Curr Top Med Chem. 2010;10(1):55-66. doi: 10.2174/156802610790232288. Curr Top Med Chem. 2010. PMID: 19929830 Review.
Rietjens IM, Vermeulen NP. Rietjens IM, et al. Among authors: vermeulen np. Environ Toxicol Pharmacol. 2002 Jul;11(3-4):147. doi: 10.1016/s1382-6689(02)00012-1. Environ Toxicol Pharmacol. 2002. PMID: 21782596 No abstract available.
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Autrup H, Barile FA, Berry SC, Blaauboer BJ, Boobis A, Bolt H, Borgert CJ, Dekant W, Dietrich D, Domingo JL, Gori GB, Greim H, Hengstler J, Kacew S, Marquardt H, Pelkonen O, Savolainen K, Heslop-Harrison P, Vermeulen NP. Autrup H, et al. Among authors: vermeulen np. Toxicol Lett. 2020 Oct 1;331:259-264. doi: 10.1016/j.toxlet.2020.04.008. Epub 2020 Apr 30. Toxicol Lett. 2020. PMID: 32360654 No abstract available.
Editorial.
Koeman JH, Vermeulen NP. Koeman JH, et al. Among authors: vermeulen np. Environ Toxicol Pharmacol. 2000 Jan 1;8(2):71. doi: 10.1016/s1382-6689(00)00043-0. Environ Toxicol Pharmacol. 2000. PMID: 10867364 No abstract available.
355 results